Altimmune ALT
5.76
0.25
4.16
%
已收盤：05/13 20:00 (臺灣)
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 5.00 | -0.26 | -21,815 | -20 | ||
| 2024Q4 | 7.21 | 107.28 | -0.33 | -24,866 | -23 | |
| 2024Q3 | 6.14 | 108.44 | -0.32 | -24,767 | -23 | |
| 2024Q2 | 6.65 | 108.55 | -0.35 | -26,745 | -25 | |
| 2024Q1 | 10.18 | 109.84 | -0.34 | -26,794 | -24 | |
| 2023Q4 | 11.25 | 106.27 | -0.56 | -33,623 | -32 | |
| 2023Q3 | 2.60 | 109.19 | -0.38 | -22,540 | -21 | |
| 2023Q2 | 3.53 | 112.13 | -0.32 | -18,007 | -16 | |
| 2023Q1 | 4.22 | 108.40 | -0.40 | -21,759 | -20 | |
| 2022Q4 | 16.45 | -0.43 | -23,094 | -22 | ||
| 2022Q3 | 12.77 | 104.66 | -0.47 | -24,752 | -24 | |
| 2022Q2 | 11.70 | 101.76 | -0.46 | -20,395 | -20 | |
| 2022Q1 | 6.09 | 100.68 | -0.44 | -19,499 | -19 | |
| 2021Q4 | 9.16 | 100.14 | -0.56 | -23,985 | -24 | |
| 2021Q3 | 11.31 | 99.18 | -0.80 | -33,204 | -34 | |
| 2021Q2 | 9.85 | 100.24 | -0.61 | -24,864 | -25 | |
| 2021Q1 | 14.13 | 100.06 | -0.38 | -14,862 | -15 | |
| 2020Q4 | 11.28 | 100.19 | -0.17 | -10,750 | -11 | |
| 2020Q3 | 13.20 | 100.41 | -0.49 | -18,324 | -18 | |
| 2020Q2 | 10.71 | 100.41 | -0.99 | -18,418 | -17 |
